NV-VSR-21-001: Promoting Vaccine Confidence in Local Communities through Partnership with Regional Health Offices
Closed
This grant is closed. Who won this program's grants before is below, and similar open grants are at the end of the page. It is in our archive of Office of the Assistant Secretary for Health notices from 2021.
Office of the Assistant Secretary for Health offered grants of up to $125,000 to the applicants described in the notice. It expected to make about 8 awards worth $750,000 in total. Applications closed on August 17, 2021.
From the official notice on Grants.gov, last changed July 9, 2021. Checked November 7, 2026.
- Award ceiling$125,000
- Total funding$750,000
- Expected awards8
- Cost sharingNot required
- Funding typeCooperative Agreement
Key dates
| Posted | July 9, 2021 |
|---|---|
| Deadline | August 17, 2021 |
| Archived by Grants.gov | September 16, 2021 |
Who can apply
This opportunity was open to the applicants described in the notice.
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
Any public or private entity located in a state or territory (which includes one of the 50 states in the United States, District of Columbia, Commonwealth of Puerto Rico, U.S. Virgin Islands, Commonwealth of the Northern Mariana Islands, American Samoa, Guam, Republic of Palau, Federated States of Micronesia, and the Republic of the Marshall Islands) is eligible to apply for an award under this announcement. State and local governments, faith-based organizations and American Indian/Alaska Native/Native American (AI/AN/NA) organizations are eligible to apply.
Is this a realistic fit?
- Past Research, Monitoring and Outcomes Definitions for Vaccine Safety awards averaged $449,286; this notice allows up to $125,000 per award.
- Most of the program's money (60% over five years) went to nonprofits.
- No cost sharing or match is required.
What the grant funds
The Office of the Assistant Secretary for Health, Office of Infectious Disease and HIV/AIDS Policy (OIDP) announces the availability of funds for Fiscal Year (FY) 2021 under the authority of sections 1702 and 1703 of the Public Health Service Act, (42 U.S.C. 300u-1 and 300u-2). OIDP oversees the National Vaccine Program that provides strategic leadership and coordination of vaccine and immunization activities among federal agencies and other stakeholders with the goal to help reduce the burden of preventable infectious disease. OIDP has maintained that vaccine confidence is critical to improving vaccination coverage rates and has prioritized its work on strengthening public trust in vaccines. This project aligns with the priority of the OASH to respond to and prevent the coronavirus disease (COVID-19) and other vaccine-preventable diseases, and strategic goals of the HHS including “Goal 2: Protect the health of Americans Where they Live, Learn, Work, and Play” and “Goal 3: Strengthen the Economic and Social Well-being of Americans Across the Lifespan”. Vaccines are among the most effective public health interventions to promote health and prevent diseases. According to the World Health Organization, vaccines prevent between two and three million deaths per year globally. An essential pillar of success for a national vaccine program is maintaining high rates of immunity in communities. To reach the necessary number of vaccinated individuals to achieve community immunity, a high level of public trust in the immunization systems, i.e., vaccine confidence, is needed. In the United States, vaccination coverage for adolescents and adults have generally remained persistently low. Even among children, where coverage rates are high at 90% or higher for most vaccines, nearly 12% of parents refuse at least one recommended vaccine for their children and approximately 30% delay one or more vaccines from being administered to their children. Additionally, non-medical exemptions from school immunization requirements have hindered higher vaccination coverage in children. These data suggest a deficiency in public trust in vaccines. If the national trend of reduced vaccine confidence continues, gains made over the past decades in preventing serious and potentially deadly diseases are threatened.
Who has won Research, Monitoring and Outcomes Definitions for Vaccine Safety grants before
From fiscal 2021 to 2025, Research, Monitoring and Outcomes Definitions for Vaccine Safety (93.344) awarded $3.1 million across 7 grant awards, an average of $449,286 per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| Cherokee Nation | Oklahoma | 1 | $898,000 |
| Hennepin Healthcare System Inc | Minnesota | 1 | $375,000 |
| Immunize Colorado | Colorado | 1 | $375,000 |
| Chickasaw Nation | Oklahoma | 1 | $375,000 |
| Alliance for a Healthier Generation Inc | Oregon | 1 | $375,000 |
Applying now
This notice no longer takes applications. Agencies often post the same opportunity again under a new number, so check the program's notices on Grants.gov and the similar open grants below.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is NV-VSR-21-001 still open?
No. It closed on August 17, 2021.
Who can apply for Promoting Vaccine Confidence in Local Communities through Partnership with Regional Health Offices?
Office of the Assistant Secretary for Health accepted applications from the applicants described in the notice. The notice adds further conditions, so read its eligibility section.
What is the deadline for Promoting Vaccine Confidence in Local Communities through Partnership with Regional Health Offices?
Closed August 17, 2021. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
Awards of up to $125,000 each. About $750,000 in total across about 8 awards.
Who has won Research, Monitoring and Outcomes Definitions for Vaccine Safety grants before?
The largest recipients over five fiscal years were Cherokee Nation, Hennepin Healthcare System Inc, Immunize Colorado. The program made 7 awards worth $3.1 million in that time.
Similar open grants
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)